rs200646278
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024312.5(GNPTAB):c.1090C>T(p.Arg364*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000031 in 1,613,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024312.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GNPTAB | NM_024312.5 | c.1090C>T | p.Arg364* | stop_gained | Exon 9 of 21 | ENST00000299314.12 | NP_077288.2 | |
| GNPTAB | XM_011538731.3 | c.1009C>T | p.Arg337* | stop_gained | Exon 9 of 21 | XP_011537033.1 | ||
| GNPTAB | XM_006719593.4 | c.1090C>T | p.Arg364* | stop_gained | Exon 9 of 19 | XP_006719656.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152162Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251448 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460932Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726876 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312 show subpopulations
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:3
- -
This sequence change creates a premature translational stop signal (p.Arg364*) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). This variant is present in population databases (rs200646278, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with mucolipidosis II (PMID: 19617216, 23773965, 27662472). ClinVar contains an entry for this variant (Variation ID: 39021). For these reasons, this variant has been classified as Pathogenic. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Mucolipidosis Pathogenic:2
Variant summary: GNPTAB c.1090C>T (p.Arg364X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g., c.1123C>T (p.Arg375X), c.1581delC (p.Cys528fsX19), c.2693delA (p.Lys898fsX13)). The variant allele was found at a frequency of 1.2e-05 in 246412 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in GNPTAB causing Mucolipidosis (1.2e-05 vs 0.0022), allowing no conclusion about variant significance. The c.1090C>T variant has been reported in the literature in multiple individuals affected with Mucolipidosis, both as a homozygous and compound heterozygous allele. These data indicate that the variant is very likely to be associated with disease. GeneReviews, a well established database, along with a clinical diagnostic laboratory classify the variant as "pathogenic." Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
Mucolipidosis type II Pathogenic:1Other:1
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at